Chemotherapy in the treatment of recurrent glioblastoma multiforme: Ifosfamide versus temozolomide

Journal of Cancer Research and Clinical Oncology

Volumn 125, Issue 7, 1999, Pages 411-418

  Paulsen, Frank ^a   Hoffmann, Wolfgang ^a   Becker, Gerd ^a   Belka, Claus ^a   Weinmann, Martin ^a   Classen, Johannes ^a   Kortmann, Rolf Dieter ^a   Bamberg, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Ifosfamide; Malignant glioma; Relapse; Temozolomide

Indexed keywords

IFOSFAMIDE; TEMOZOLOMIDE;

ADULT; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; GLIOBLASTOMA; HEMATURIA; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT CANCER; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DACARBAZINE; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLIOBLASTOMA; HUMANS; IFOSFAMIDE; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0033061814     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050295     Document Type: Article

References (45)

1. Bamberg M, Hess CF (1992) Radiation therapy of malignant gliomas. Onkologie 15:178-189
2. Bamberg M, Budach V, Stuschke M, Gerhard L (1988) Preliminary results with the nitrosourea derivative ACNU in the treatment of malignant gliomas. Radiother Oncol 12:25-29
3. Barker FG, Chang SM, Prados MD, Gutin PH (1996) Response to carmustine (BCNU), tumor control, and survival in recurrent glioblastoma multiforme. Proc Am Soc Clin Oncol 15:161
4. Bogdahn U, Drenkard D, Lutz M, Apfel R, Behl C (1991) In vitro studies on drug interaction of ifosfamide and ACNU in primary and metastatic human brain tumours. J Cancer Res Clin Oncol 117 [Suppl IV]: S157-S163
5. Bower M, Newlands ES, Bleehen NM, Brada M, Begent RJ, Calvert H, Colquhoun I, Lewis P, Brampton MH (1997) Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma. Cancer Chemother Pharmacol 40:484-488
6. Buckner JC, Burch PA, Schaefer PL, Mailliard JA, Dinapoli RP, Scheithauer BW, Novotny PJ, Rowland KM, Kugler JW, Morton RF (1996) Phase II trial of nitrogen mustard, vincristine, and procarbazine (MOP) in patients with recurrent glioma: NCCTG results. Proc Am Soc Clin Oncol 15:155
7. Chang S, Schold C, Spence, A, Berger M, McAllister L, Mehta M, Gilbert M, Fulton D, Prados M (1996) Phase I/II study of paclitaxel chemotherapy for recurrent malignant glioma: preliminary report. North American Brain Tumor Consortium. Proc Am Soc Clin Oncol 15:153
8. Chastagner P, Sommelet-Olive D, Kalifa C, Brunat-Mentigny M, Zucker JM, Demeocq F, Baranzelli MC, Tron P, Bergeron C, Pein F et al (1993) Phase II study of ifosfamide in childhood brain tumors: a report by the French Society of Pediatric Oncology (SFOP). Med Pediatr Oncol 21:49-53
9. Cloughesy T, Black K, Grous JJ, Huang S, Gobin P, Hoh C, Farabani K, Vinuela F, Graney WF (1996) Ascending dose, intra-arterial RMP-7 and carboplatin are safe and tolerable in recurrent malignant glioma patients. Proc Am Soc Clin Oncol 15:160
10. Eagan RT, Dinapoli RP, Cascino TL, Scheithauer B, O'Neill BP, O'Fallon JR (1987) Comprehensive phase II evaluation of aziridinyl-benzoquinone (AZQ, Diaziquone) in recurrent human primary brain tumors. J Neurooncol 5:309-314
11. Elliott TE, Buckner JC, Cascino TL, Levitt R, O'Fallon JR, Scheithauer BW (1991) Phase II study of ifosfamide with mesna in adult patients with recurrent diffuse astrocytoma. J Neurooncol 10:27-30
12. Gregor A, Rampling R, Aapro M, Malmstrom P, Whittle IR, Rye R, Stewart M, Sellar R, Memierre B, Ironside JW, Wahlby S, Smyth JF (1992) Phase II study of tauromustine in malignant glioma. Eur J Cancer 28A: 1959-1962
13. Heideman RL, Douglass EC, Langston JA, Krischer JP, Burger PC, Kovnar EH, Kun LE, Friedman HS, Kadota R (1995) A phase II study of every day high-dose ifosfamide in pediatric brain tumors: a Pediatric Oncology Group study. J Neurooncol 25:77-84
14. Heimans JJ, Postma TJ, Vermorken JB, Groeningen CJ van, Wolbers JG, Beenen LFM, Hoekstra OS, Slotman BJ, Taphoorn MJB, Zonneberg BA (1998) A phase II study of paclitaxel in patients with recurrent high grade glioma. J Neurooncol 39:152
15. Honore S, Chinot O, Dufour H, Bouillaut P, Braguer D, Grisoli F (1998) Temodal (temozolomide) in nitrosoureas pre-treated malignant glioma patients. Single institute study. J Neurooncol 39:151
16. Janus TJ, Hohl RJ (1996) Phase II trial of carboplatin, 5-FU, and interferon alpha 2A for recurrent malignant gliomas. Proc Am Soc Clin Oncol 15:156
17. Karlsson UL, Leibel SA, Wallner K, Davis LW, Brady LW (1992) Brain. In: Perez CA, Brady LW (eds) Principles and practice of radiation oncology. Lippincott, Philadelphia, pp 515-552
18. Krauseneck P, Müller B, Hofer D, Becker G (1998) High dose procarbazine and 5-FU is an effective second line therapy of malignant gliomas. J Neurooncol 39:154
19. Lange OF, Haase KD, Scheef W (1987) Simultaneous radio-and chemotherapy of inoperable brain tumors. Radiother Oncol 8:309-314
20. Lederman GS, Odaimi M, Wertheim S, Lowry J, Fine M, Schultz D, Wrzolek M, Rashid H, Wang L, Qian G, Silverman P, Lombardi E (1996) Survival benefit of fractionated stereotactic radiosurgery and concurrent taxol for recurrent high grade primary brain tumors. Proc Am Soc Clin Oncol 15:158
21. Levin VA (1985) Chemotherapy of primary brain tumors. Neurol Clin 3:855-866
22. Miser J, Krailo M, Smithson W, Belasco J, Ortega J, Hammond GD (1989) Treatment of children with recurrent brain tumors with ifosfamide, etoposide, and mesna. Proc Am Soc Clin Oncol 8:84
23. Newlands ES, O'Reilly SM, Glaser MG, Bower M, Evans H, Brock C, Brampton MH, Colquhoun I, Lewis P, Rice-Edwards JM, Illingworth RD, Richards PG (1996) The Charing Cross Hospital experience with temozolomide in patients with gliomas. Eur J Cancer 32A:2236-2241
24. Ninane J, Baurain R, Krater J de, Cornu G (1986) Pharmacokinetics of ifosfamide in children. Minutes of SIOP meeting, Budapest, Hungary, pp 224-225
25. O'Reilly SM, Newlands ES, Glaser MG, Brampton M, Rice-Edwards JM, Illingworth RD, Richards PG, Kennard C, Colquhoun IR, Lewis P, Stevens F (1993) Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumors. Eur J Cancer 29A:940-942
26. Prados MD, Spence A, Schold C, Robbins I, Mehta M, Berger M, Kuhn J, Rector D, Chang S, Gilbert M (1996) A phase II trial of phenylacetic acid for recurrent malignant glioma. Preliminary report of the North American Brain Tumor Consortium. Proc Am Soc Clin Oncol 15:156
27. Rodier JM, Da Costa L, Adams D, Berger E, Haie C, Parker F, Ciolocca C, Armand JP (1996) Fotemustine and cisplatin association in patients with recurrent malignant glioma. Proc Am Soc Clin Oncol 15:157
28. Rudà R, Nobile M, Borgognone M, Schiffer D, Soffietti R (1998) Response to PCV chemotherapy of recurrent astrocytic gliomas. J Neurooncol 39:153
29. Sanson M, Ameri A, Monjour A, Sahmoud T, Ronchin P, Poisson M, Delattre JY (1996) Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study. Eur J Cancer 32A:2229-2235
30. Seegenschmiedt MH, Karlsson UL, Black P, Brady LW (1995) Thermoradiotherapy for brain tumors. Three cases of recurrent malignant astrocytoma and review of clinical experience. Am J Clin Oncol 18:510-518
31. Shrieve DC, Alexander E III, Wen PY, Fine HA, Kooy HM, Black PM, Loeffler JS (1995) Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 36:275-282
32. Sobol RE, Fakhrai H, Shawler D, Gjerset R, Dorigo O, Carson C, Khaleghi T, Koziol J, Shiftan TA, Royston I (1995) Interleukin-2 gene therapy in a patient with glioblastoma. Gene Ther 2:164-167
33. Spence AM, Berger MS, Livingston RB, Ali-Osman F, Griffin B (1992) Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea. J Neurooncol 12:187-191
34. Stevens MF, Hickman JA, Langdon SP, Chubb D, Vickers L, Stone R, Baig G, Goddard C, Gibson NW, Slack JA, Newton C, Lunt E, Fizames C, Lavelle F (1987) Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-(2-chlorethyl)imidazo[5,l,d]-l,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M&B 39831), a novel drug with potential as an alternative to dacarbazine. Cancer Res 47:5846-5852
35. Stewart DJ (1989) The role of chemotherapy in the treatment of gliomas in adults. Cancer Treat Rev 16:129-160
36. Stewart DJ, Hugenholtz H, DaSilva VE, Benoit BG, Richard MT, Verma T, Earhart R, Robillard I (1992) Phase II study of weekly intravenous menogaril in the treatment of recurrent astrocytomas in adults. J Neurooncol 13:183-188
37. Stupp R, Maeder P, Pica A, Wurm R, Hungerbühler HP, Villemure G, Baumert B, Büttner W, Tribolet N de, Lejeune F, Mirimanoff RO, Leyvraz S (1998) Improved outcome with chemotherapy with temozolomide for recurrent glioblastomas and anaplastic astrocytoma. Neurooncol 39:151
38. Taylor SA (1994) New agents in the treatment of primary brain tumors. J Neurooncol 20:141-153
39. Taylor SA, Crowley J, Pollock TW, Eyre HJ, Jaeckle C, Hynes HE, Stephens RI (1991) Objective antitumor activity of acivin (AT-125) in patients with recurrent CNS malignancies: a Southwest Oncology Group trial. J Clin Oncol 9:1476-1479
40. Taylor SA, Crowley J, Townsend J, Vogel FS, Eyre H, Braun JJ, Goodwin JJ (1993) Phase II evaluation of echinomycin (NSC-526417) in patients with central nervous system malignancies: a Southwest Oncology Group study. J Neurooncol 15:181-184
41. Tirelli U, D'Incalci M, Canetta R, Tumulo S, Franchin G, Veronesi A, Galligioni E, Trovo MG, Rossi C, Grigoletto E (1984) Etoposide (VP-16-213) in malignant brain tumors: a phase II study. J Clin Oncol 2:432-437
42. Wedge SR, Porteous JK, Glaser MG, Marcus K, Newlands ES (1997) In vitro evaluation of temozolomide combined with X-irradiation. Anticancer Drugs 8:92-97
43. Wong ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, Levin VA, Yung WKA (1996) Time to tumor progression as a measure of efficacy in phase II chemotherapy trials for recurrent malignant gliomas. Proc Am Soc Clin Oncol 15:153
44. Yung A, Levin V, Albright R, Olson J, Fredericks R, Fink K, Prados M, Brada M, Spence A, Bruner J, Yue N, Dugan M, the Temodal Brain Group (1998) Randomized trial of temodal versus procarbazine in glioblastoma multiforme at first relapse. Neurooncol 39:102
45. Yung WKA, Mechtler L, Gleason MJ (1991) Intravenous carboplatin for recurrent malignant glioma: a phase II study. J Clin Oncol 9:860-864